Human Keratinocyte Cell Lines Differ in the Expression of the Collagenolytic Matrix Metalloproteinases-1, -8, and -13 and of TIMP-1

Biological Chemistry

Volumn 381, Issue 5-6, 2000, Pages 509-516

  Bachmeier, Beatrice E ^a   Fritz, Hans ^a   Fink, Edwin ^a   Nerlich, Andreas G ^a   Boukamp, Petra ^b   Lichtinghagen, Ralf ^c   Tschesche, Harald ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BIELEFELD UNIVERSITY   (Germany)

Author keywords

Collagenase; HaCaT cells; In vitro study; Keratinocyte cell lines; MMP; Tumorigenicity

Indexed keywords

COLLAGENASE; COLLAGENASE 3; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER CELL; CELL LINE; CELLULAR DISTRIBUTION; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EPITHELIUM TUMOR; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

BASE SEQUENCE; BLOTTING, WESTERN; CELL EXTRACTS; CELL LINE; COLLAGEN; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0033937345     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2000.065     Document Type: Article

References (46)

1. Airola, K., Johansson, N., Kariniemi, A. L., Kähäri, V. M., and Saarialho-Kere, U. K. (1997). Human collagenase-3 is expressed in malignant squamous epithelium of the skin. Invest. Dermatol. 109, 225-231.
2. Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A. L., Keski-Oja, J., and Saarialho-Kere, U. K. (1999). Expression of collagenases-1 and-3 and their inhibitors TIMP-1 and-3 correlates with the level of invasion in malignant melanomas. Brit. J. Cancer. 80, 733-743.
3. Bachmeier, B., Boukamp, P., Lichtinghagen, R., Fusenig, N., and Fink, E. (1998). Comparative study on protease profiles of human keratinocyte cell lines and derived malignant clones. Biol. Chem. 379 (Supplement), S47.
4. Bachmeier, B., Boukamp, P., Lichtinghagen, R., Fusenig, N., and Fink, E. (2000). Matrix Metalloproteinases-2, -3, -7, -9, and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol. Chem. 381, 497-507.
5. Bailly, C., Dreze, S., Asselineau, D., Nusgens, B., Lapiere, C. M., and Darmon, M. (1990). Retinoic acid inhibits the production of collagenase by human epidermal keratinocytes. J. Invest. Dermatol. 94, 47-51.
6. Balbin, M., Pendas, A. M., Uria, J. A., Jimenez, M. G., Freje, J. P., and Lopez-Otin, C. (1999). Expression and regulation of colla-genase-3 (MMP-13) in human malignant tumors. APMIS 107, 45-53.
7. Basset, P., Okada, A., Chenard, M. P., Kannan, R., Stoll, I., Anglard, P., Bellocq, J. P., and Rio, M. C. (1997). Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol. 15, 535-541.
8. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. (1993). Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4, 197-250.
9. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratino-cyte cell line. J. Cell. Biol. 106, 761-771.
10. Boukamp, P., Stanbridge, E. J., Foo, D. Y., Cerutti, P. A., and Fusenig, N. E. (1990). c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res. 50, 2840-2847.
11. Cazorla, M., Hernandez, L., Nadal, A., Balbin, M., Lopez, J. M., Vi-zoso, F., Fernandez, P. L., Iwata, K., Cardesa, A., Lopez-Otin, C., and Campo, E. (1998). Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J. Pathol. 186, 144-150.
12. Chubinskaya, S., Huch, K., Mikecz, K., Cs-Szabo, G., Hasty, K. A., Kuettner, K. E., and Cole, A. A. (1996). Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab. Invest. 74, 232-240.
13. Cole, A. A., Chubinskaya, S., Schumacher, B., Huch, K., Szabo, G., Yao, J., Mikecz, K., Hasty, K. A., and Kuettner, K. E. (1996). Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271, 11023-11026.
14. Freije, J. M., Diez-Itza, I., Balbin, M., Sanchez, L. M., Blasco, R., Tolivia, J., and Lopez-Otin, C. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metallopro-teinase produced by breast carcinomas. J. Biol. Chem. 269, 16766-16773.
15. Gadher, S. J., Schmid, T. M., Heck, L. W., and Woolley, D. E. (1989). Cleavage of collagen type X by human synovial collagenase and neutrophil elastase. Matrix 9, 109-115.
16. Geisler, S., Lichtinghagen, R., Boker, K. H., and Veh, R. W. (1997). Differential distribution of five members of the matrix metallo-proteinase family and one inhibitor (TIMP-1) in human liver and skin. Cell Tissue Res. 289, 173-183.
17. Goldberg, G. I., Wilhelm, S. M., Kronberger, A., Bauer, E. A., Grant, G. A., and Eisen, A. Z. (1986). Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261, 6600-6605.
18. Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S., and He, C. S. (1989). Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207-8211.
19. Hanemaaijer, R., Sorsa, T., Konttinen, Y. T., Ding, Y., Sutinen, M., Visser, H., van Hinsbergh, V. W., Helaakoski, T., Kainulainen, T., Ronka, H., Tschesche, H., and Salo, T. (1997). Matrix metallo-proteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factoralpha and doxycycline. J. Biol. Chem. 272, 31 504-31509.
20. Hasty, K. A., Jeffrey, J. J., Hibbs, M. S., and Welgus, H. G. (1987). The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262, 10048-10052.
21. Hsu, S. M., and Raine, L. (1981). Protein A, avidin, and biotin in immunohistochemistry. Histochem. Cytochem. 29, 1349-1353.
22. Johansson, N., Airola, K., Grenman, R., Kariniemi, A. L., Saarialho-Kere, U., and Kähäri, V. M. (1997a). Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151, 499-508.
23. Johansson, N., Westermarck, J., Leppä, S., Häkkinen, L., Koivis-to, L., Lopez-Otin, C., Peltonen, J., Heino, J., and Kähäri, V. M. (1997b). Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ. 8, 243-250.
24. Johnsen, M., Lund, L. R., Romer, J., Almholt, K., and Dano, K. (1998). Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10, 667-671.
25. Kähäri, V. M., and Saarialho-Kere, U. (1997). Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213.
26. Kähäri, V. M., Johansson, N., Grenman, R., Airola, K., and Saarialho-Kere, U. (1998). Expression of collagenase-3 (MMP-13) by tumor cells in squamous cell carcinomas of the head and neck. Adv. Exp. Med. Biol. 451, 63-68.
27. Kameyama, K. (1996). Expression of MMP-1 in the capsule of thyroid cancer-relationship with invasiveness. Pathol. Res. Pract. 192, 20-26.
28. Knäuper, V., Lopez-Otin, C., Smith, B., Knight, G., and Murphy, G. (1996). Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544-1550.
29. Lichtinghagen, R., Helmbrecht, T., Arndt, B., and Boker, K. H. (1995). Expression pattern of matrix metalloproteinases in human liver. Eur. J. Clin. Chem. Clin. Biochem. 33, 65-71.
30. Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L., and Thorgeirsson, U. P. (1992). Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis. 12, 168-184.
31. Mainardi, C. L., Pourmotabbed, T. F., and Hasty, K. A. (1991). Inflammatory phagocytes and connective tissue degrading metalloproteinases. Am. J. Med. Sci. 302, 171-175.
32. Matrisian, L. M. (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6, 121-125.
33. Matrisian, L. M. (1992). The matrix-degrading metalloproteinases. Bioessays 14, 455-463.
34. McCarthy, K., Maguire, T., McGreal, G., McDermott, E., O'Higgins, N., and Duffy, M. J. (1999). High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int. J. Cancer 84, 44-48.
35. Mignatti, P., and Rifkin, D. B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
36. Mitchell, P. G., Magna, H. A., Reeves, L. M., Lopresti-Morrow, L. L., Yocum, S. A., Rosner, P. J., Geoghegan, K. F., and Hambor, J. E. (1996). Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761-768.
37. Murphy, G., Reynolds, J. J., Bretz, U., and Baggiolini, M. (1977). Collagenase is a component of the specific granules of human neutrophil leucocytes. Biochem. J. 162, 195-197.
38. Murray, G. I., Duncan, M. E., O'Neil, P., McKay, J. A., Melvin, W. T., and Fothergill, J. E. (1998). Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185, 256-261.
39. Murray, G. I., Duncan, M. E., O'Neil, P., Melvin, W. T., and Fothergill, J. E. (1996). Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med. 2, 461-462.
40. Petersen, M. J., Woodley, D. T., Stricklin, G. P., and O'Keefe, E. J. (1987). Production of procollagenase by cultured human keratinocytes. J. Biol. Chem. 262, 835-840.
41. Sakurai, Y., Otani, Y., Kameyama, K., Hosoda, Y., Okazaki, I., Kubota, T., Kumai, K., and Kitajima, M. (1997a). Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers. Jpn. J. Cancer Res. 88, 401-406.
42. Sakurai, Y., Otani, Y., Kameyama, K., Igarashi, N., Kubota, T., Kumai, K., and Kitajima, M. (1997b). The role of stromal cells in the expression of interstitial collagenase (matrix metallopro-teinase-1) in the invasion of gastric cancer. J. Surg. Oncol. 66, 168-172.
43. Schmitt, M., Jänicke, F., Moniwa, N., Chucholowski, N., Pache, L., and Graeff, H. (1992). Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe-Seyler 373, 611-622.
44. Seltzer, J. L., Eisen, A. Z., Bauer, E. A., Morris, N. P., Glanville, R. W., and Burgeson, R. E. (1989). Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J. Biol. Chem. 264, 3822-3826.
45. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
46. Woessner, J. F. (1998). The matrix metalloproteinase family. In: Matrix Metalloproteinases, W. C. Parks and R. P. Mecham, eds. (San Diego, USA: Academic Press), pp. 1–14.